-+ 0.00%
-+ 0.00%
-+ 0.00%

Puma Biotechnology Narrows FY2026 Sales Guidance from $224.000M-$231.000M to $224.000M-$227.000M

Benzinga·11/05/2026 21:23:09
Listen to the news
Puma Biotechnology (NASDAQ:PBYI) narrows FY2026 sales outlook from $224.000 million-$231.000 million to $224.000 million-$227.000 million.